22-23787203-C-G
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 4P and 1B. PM1PM2BP4
The NM_003073.5(SMARCB1):c.34C>G(p.Gln12Glu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q12R) has been classified as Uncertain significance.
Frequency
Consequence
NM_003073.5 missense
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- intellectual disability, autosomal dominant 15Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- rhabdoid tumor predisposition syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- SMARCB1-related schwannomatosisInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics
- familial multiple meningiomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- schwannomatosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- complex neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| SMARCB1 | NM_003073.5 | c.34C>G | p.Gln12Glu | missense_variant | Exon 1 of 9 | ENST00000644036.2 | NP_003064.2 | |
| SMARCB1 | NM_001362877.2 | c.34C>G | p.Gln12Glu | missense_variant | Exon 1 of 9 | NP_001349806.1 | ||
| SMARCB1 | NM_001317946.2 | c.34C>G | p.Gln12Glu | missense_variant | Exon 1 of 9 | NP_001304875.1 | ||
| SMARCB1 | NM_001007468.3 | c.34C>G | p.Gln12Glu | missense_variant | Exon 1 of 9 | NP_001007469.1 | 
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD4 exome Cov.: 30 
GnomAD4 genome  
ClinVar
Submissions by phenotype
not provided    Uncertain:1 
This sequence change replaces glutamine, which is neutral and polar, with glutamic acid, which is acidic and polar, at codon 12 of the SMARCB1 protein (p.Gln12Glu). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SMARCB1-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at